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Introduction
Cloning of the human uncoupling protein 1 (UCP1)
homologue, UCP3, has initiated research toward the
putative role of this novel protein (1). On the basis of
its amino acid sequence homology (approximately
58%) with UCP1, a similar role to that of UCP1 — that
is, lowering the proton motive force and reducing ADP
phosphorylation and thereby increasing energy expen-
diture (a process referred to as uncoupling) — has been
attributed to UCP3. The supposed uncoupling po-
tential of UCP3, together with the chromosomal 
mapping in the vicinity of genes associated with obe-
sity and diabetes (2, 3), has contributed to the idea
that UCP3 is a candidate protein involved in the devel-
opment of obesity. Indeed, a positive relation has been
observed between UCP3 mRNA levels and energy
expenditure in Pima Indians (4). However, the pro-
posed physiological role of UCP3 as a mitochondrial
uncoupler, and thus its relation to energy expenditure
and obesity, is still debatable. In particular, studies in
which the level of UCP3 has been overexpressed by
genetic manipulation have had conflicting results
(5–7). Thus, on the one hand, overexpression of UCP3
lowered the mitochondrial membrane potential in
yeast (8, 9) and increased state 4 respiration in mito-
chondria isolated from mice skeletal muscle (10). On
the other hand, however, expressing human UCP3 in
yeast to supraphysiological levels did not induce
uncoupling and therefore was considered an artifact
(7). Similarly, mitochondria derived from transgenic
mice overexpressing UCP3 by approximately 20-fold
showed only noninducible uncoupling (6). Finally,
mitochondria isolated from UCP3-ablated mice have
been shown to be more tightly coupled in vitro (11,
12) and in vivo (13) in some but not all (6) studies.
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Phosphocreatine (PCr) resynthesis rate following intense anoxic contraction can be used as a sensi-
tive index of in vivo mitochondrial function. We examined the effect of a diet-induced increase in
uncoupling protein 3 (UCP3) expression on postexercise PCr resynthesis in skeletal muscle. Nine
healthy male volunteers undertook 20 one-legged maximal voluntary contractions with limb blood
flow occluded to deplete muscle PCr stores. Exercise was performed following 7 days consumption
of low-fat (LF) or high-fat (HF) diets. Immediately following exercise, blood flow was reinstated, and
muscle was sampled after 20, 60, and 120 seconds of recovery. Mitochondrial coupling was assessed
by determining the rate of PCr resynthesis during recovery. The HF diet increased UCP3 protein con-
tent by approximately 44% compared with the LF diet. However, this HF diet–induced increase in
UCP3 expression was not associated with any changes in the rate of muscle PCr resynthesis during
conditions of maximal flux through oxidative phosphorylation. Muscle acetylcarnitine, free-crea-
tine, and lactate concentrations during recovery were unaffected by the HF diet. Taken together, our
findings demonstrate that increasing muscle UCP3 expression does not diminish the rate of PCr
resynthesis, allowing us to conclude that the primary role of UCP3 in humans is not uncoupling.
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However, it should be noted that UCP3-ablated mice
responded normally to fasting and lacked an apparent
phenotype change (11, 12).
A more physiological intervention demonstrated that
a fasting-induced increase in UCP3 expression (two- to
threefold) in rats did not affect mitochondrial coupling
in vitro (14) or in vivo (15). However, when T3 (thyrox-
ine) treatment was used, upregulation of UCP3
(approximately threefold) coincided with increased
uncoupling in vivo (16) and in vitro (17–19).
The inconsistency with regard to increased UCP3
expression being associated with uncoupled mitochon-
drial respiration under physiological conditions, togeth-
er with the observation that substances present under
physiological conditions (like superoxide and GDP) can
induce or inhibit the uncoupling activity of UCP3,
underscores the need to investigate this phenomenon
in humans. Manipulation of UCP3 content under phys-
iological conditions, with simultaneous assessment of
the coupling of mitochondria in their native environ-
ment, should provide important information whether
the primary role of UCP3 is to uncouple mitochondria
and hence to modulate energy expenditure.
In the present study, high-intensity exercise with
limb blood flow occlusion was used as a model to
deplete muscle PCr stores. To test whether the primary
role of UCP3 is to uncouple mitochondrial respira-
tion, we used the rate of PCr resynthesis during subse-
quent recovery with limb blood flow reinstated. On
the basis of earlier reports relating to the stimulatory
effect of high-fat (HF) feeding on UCP3 mRNA expres-
sion (20–22), UCP3 protein content was manipulated
by feeding healthy human subjects an HF diet. We
hypothesized that an HF diet-induced increase in
UCP3 protein content would decrease mitochondrial
energy coupling in vivo, which would be reflected by a
decrease in the rate of PCr resynthesis during recovery.
Methods
Subjects. Nine healthy, physically inactive, normoten-
sive, male, Caucasian subjects enrolled in the study
after giving their written informed consent to take part.
Subject characteristics are shown in Table 1. The insti-
tutional Medical-Ethical Committee of Maastricht
University approved the study.
Experimental protocol. After a preliminary familiariza-
tion visit, subjects were requested to visit the laborato-
ry on two further occasions each separated by at least
12 days. On the first occasion, subjects reported to the
laboratory after consuming a prescribed low-fat (LF)
diet for 7 days (a venous blood sample was also
obtained from an anticubital vein after an overnight
fast on day 6). On reporting to the laboratory, subjects
performed a high-intensity exercise test on a Cybex II
dynamometer (Ronkonkoma, New York, USA). The leg
to be exercised was positioned in line with the lever arm
of the Cybex II isokinetic dynamometer, and a strap
was placed securely around the ankle to ensure trans-
fer of force. To minimize movement, subjects were
secured around the midriff and the lower-thigh region
of the limb to be exercised. Before the initiation of exer-
cise, subjects were prepared for muscle biopsy sampling
by having three incisions (each separated by 2.5 cm)
through the skin and muscle fascia under local anes-
thesia (2% xylocaine). After this procedure, an inflat-
able limb occlusion cuff was placed around the upper
portion of the leg to be exercised and was inflated to
more than 180 mm Hg while subjects rested in the
chair of the Cybex ergometer. The cuff was maintained
at this pressure for 3 minutes (in an attempt to deplete
muscle oxygen stores), and subjects then performed 20
maximal voluntary knee contractions (MVCs) at an
angular velocity of 90° per second. The subjects were
verbally encouraged to produce maximal effort every 4
seconds, the rhythm being indicated by a metronome.
Force generated during exercise was recorded on a PC.
Immediately after exercise (less than 2 seconds), limb
blood flow was reinstated, and needle muscle biopsies
(23) were taken 20, 60, and 120 seconds after the rein-
statement of blood flow, as PCr resynthesis is known to
be almost complete during the initial 2 minutes of
recovery in this experimental model (24). All muscle
biopsy samples were snap frozen by plunging the nee-
dle into liquid nitrogen directly after removal from the
limb. One portion of the sample was subsequently
freeze dried and stored at –80°C, and the remainder
was stored wet in liquid nitrogen.
After this exercise session, HF diets were handed
out; subjects consumed this HF diet, which was
isocaloric with respect to the LF diet, for 7 days. Dur-
ing this period, subjects undertook the same experi-
mental procedures as those described above. To pre-
vent trauma-induced alterations in PCr resynthesis,
the leg performing the first experimental trial was
randomly chosen, and the contralateral leg was exer-
cised during the second experimental trial. Blood
samples were analyzed for lipid-related parameters,
and muscle samples were analyzed for UCP3 protein
content, energy-rich phosphates, creatine, lactate,
free-carnitine, and acetylcarnitine concentrations.
Pretesting trials. Body composition was assessed after
an overnight fast using the hydrostatic weighing.
Residual lung volume was measured by the helium-
dilution technique using a spirometer (Volugraph
2000, Mijnhardt, The Netherlands). Percentage body
fat was calculated using Siri’s equation (25). Body mass
was measured before and after LF and HF feeding.
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Table 1
Subject characteristics
Parameter Mean (± SEM)
Age (yr) 21.3 (0.6)
Height (m) 1.84 (0.03)
Weight (kg) 79.1 (7.0)
BMI (kg/m2) 23.3 (1.6)
Body fat (%) 14.4 (3.6)
Diets. Metabolizable energy intake and macronutri-
ent composition of the diet was calculated using the
Dutch food composition table (26). In this table,
metabolizable energy is calculated by multiplying the
amount of protein, fat, and carbohydrate with the
Atwater factors (16.74, 37.66, and 16.74 kJ/g for pro-
tein, fat, and carbohydrate, respectively). The HF diet
consisted of 60% of energy as fat, 25% of energy as car-
bohydrate, and 15% of energy as protein. The LF diet
consisted of 30% of energy as fat, 55% of energy as car-
bohydrate, and 15% of energy as protein. Subjects’
energy requirements were based on calculated basal
metabolic rate (27) multiplied by an activity level of
1.7 (28). Food items were packed in daily portions and
were handed out every other day. Subjects were
instructed to strictly adhere to the diet with ad libi-
tum consumption of water and tea.
Blood and muscle analysis. Fasting venous blood sam-
ples collected on day 6 after both diets was collected in
tubes containing EDTA and was immediately cen-
trifuged at 4,000 rpm for 10 minutes at 4°C. Plasma
was frozen in liquid nitrogen and stored at –80°C until
further analysis of FFAs (Wako NEFA C test kit; Wako
chemicals, Neuss, Germany), glycerol, and triglycerides
(glycerol kinase-lipase method; Boehringer, Mannheim,
Germany) was undertaken. All analyses were performed
on an automated centrifugal spectrophotometer
(Cobas Fara, La Roche, Basel, Switzerland).
Freeze-dried muscle samples were dissected free
from visible blood and connective tissue and pow-
dered, and approximately 10 mg was extracted in 0.5
M perchloric acid containing 1 mM EDTA. After cen-
trifugation, the neutralized supernatant (2.2 M
KHCO3) was used for spectrophotometric analyses of
PCr, creatine, and lactate (29). The same extract was
used for determination of free-carnitine and acetyl-
carnitine concentrations (30).
Western blotting and antibody validation. The wet mus-
cle tissue samples obtained at 20, 60, and 120 seconds
were pooled and homogenized in ice-cold Tris-EDTA
buffer at pH 7.4 to determine UCP3 protein content
by Western blotting. The homogenates were sonicat-
ed four times for 15 seconds. Routine polyacrylamide
SDS gel electrophoresis was performed essentially
according to the procedure described by Laemmli
(31). Nitrocellulose sheets were preincubated for 60
minutes with blocking buffer containing 5% nonfat
dry milk (Bio-Rad, Hercules, California, USA) and
0.05% Tween-20 (Sigma-Aldrich, St. Louis, Missouri,
USA) in PBS. An affinity-purified, previously validat-
ed (32) polyclonal antibody raised in rabbit against a
20-amino-acid peptide that comprised amino acids
147–166 of human UCP3 was used to assess UCP3
protein levels. The peptide used has no homology
with UCP2. A wide range of positive and negative
specificity tests was performed to validate this anti-
body. In immunolocalization studies, the affinity-
purified antibody was used on human skeletal mus-
cle and on H9C2 cells. H9C2 cells lack endogenous
protein expression of UCP2 and UCP3; thus, untreat-
ed cells failed to show any detectable signal. In H9C2
cells transfected with human UCP3 (hUCP3), a punc-
tate mitochondrial staining appeared, which was
completely abolished after preincubation of the anti-
body with the peptide (32). Also, in human skeletal
muscle, the antibody raised a mitochondrial signal
that was undetectable after preincubation, as estab-
lished by light microscopy (32). In Western blotting,
the specificity was tested (Figure 1a) by using tissues
known to express UCP3 at the protein level (skeletal
muscle) or tissues lacking endogenous expression of
UCP3 but with reported UCP2 expression (human
liver, human lung, and human white adipose tissue).
In addition, skeletal muscle from mice overexpressing
human UCP3 (10) and their corresponding litter-
mates was examined (Figure 1b). Similar to previous
observations (32), no bands were present in human
liver, human lung, human white adipose tissue, and
skeletal muscle from wild-type littermates, whereas in
human skeletal muscle as well as in skeletal muscle
from mice overexpressing human UCP3, a clear band
representing UCP3 was detected. None of the samples
showed cross-reactivity with proteins of distinct
molecular mass (including UCP2) in the region exam-
ined. Similar to our findings in immunolocalization
studies, no band was detected in Western blotting
after preincubation of the antibody with the peptide
(data not shown).
Taken together, these findings have convinced us that
on affinity purification, the antibody referred to as
1331 (Eli Lilly and Co., Indianapolis, Indiana, USA)
specifically recognizes human UCP3 in skeletal muscle
without cross-reacting with any of the other uncou-
pling proteins presently known.
Incubation with this affinity-purified polyclonal
antibody in a 1:1,000 dilution in blocking buffer was
carried out overnight at room temperature with gen-
tle shaking. After washing, blots were incubated for 60
minutes at room temperature with horseradish per-
oxidase–conjugated swine anti-rabbit Ig (SWARPO,
DAKO, Glostrup, Denmark) diluted 1:10,000 in
blocking buffer. Blots were subsequently washed 
for 90 minutes in 0.05% Tween-20/PBS and for 10 
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Figure 1
(a) Representative Western blot of human lung (1), human liver (2),
human white adipose tissue (3), and two human vastus lateralis mus-
cle samples (4 and 5) after loading similar amounts of protein. (b)
Western blot of medial gastrocnemius muscle from a transgenic
mouse overexpressing human UCP3 (1) and a wild-type littermate
(2). Note the lack of cross-reactivity in tissues known to express
UCP2 but not UCP3 (a) and the lack of cross-reactivity with endoge-
nous mouse UCP3 (b).
minutes in PBS. Chemiluminescence was performed
using a Super Signal West Dura Extended kit (Pierce,
Rockford, Illinois, USA).
Statistics. Paired Student’s t tests were performed to
compare the effect of both diets on blood parameters
and UCP3 content. The general linear model (GLM) for
multivariate analysis command (SPSS for Windows
release 10.1.0) was used to perform a two-way ANOVA
to examine the effect of the main factors (diet and time)
on muscle metabolites.
Results
Exercise protocol. Recording of contractile performance of
the knee-extensor muscles during 20 maximal voluntary
contractions with limb blood flow occluded showed a
gradual decline in torque production (approximately
45%) (Figure 2). The total amount of work (area under
the curve) performed after the two diets was similar, as
demonstrated by the close similarity in muscle torque
production throughout the 20 contractions (Figure 2).
This also ensures that any metabolic differences observed
between treatments could not be explained by a differ-
ence in the amount of work performed during exercise.
Blood metabolites. Plasma FFAs and triglyceride con-
centrations after the HF diet were significantly greater
than after the LF diet (194 ± 15 mol/l vs. 274.1 ± 16
mol/l, P < 0.05, and 876 ± 300 mol/l vs. 818.0 ± 309
mol/l, P < 0.05, respectively). Both findings indicate
good compliance with the diets.
Muscle UCP3 content and metabolite concentrations. UCP3
protein content was greater (approximately 44%) after
the HF diet than after the LH diet (0.69 ± 0.10 AU vs.
0.48 ± 0.1 AU, P < 0.05) (Figure 3). Figure 4 shows mus-
cle PCr concentrations at 20, 60, and 120 seconds of
recovery with limb blood flow reinstated. As expected,
muscle PCr concentrations increased during recovery,
but no difference in response was observed at any time
point with respect to diet.
Muscle lactate and creatine concentra-
tions declined over the course of recovery
in both groups. Furthermore, no differ-
ences in lactate or creatine concentrations
were observed across diets at any time
point during recovery (Table 2).
Muscle acetylcarnitine concentrations
increased during recovery in both experi-
mental groups (Table 2). However, there
was no significant difference between
groups at any time point during recovery.
The changes in muscle acetylcarnitine on
each diet were mirrored by changes in mus-
cle free-carnitine concentrations.
Discussion
Since the cloning of human UCP3, a UCP1
homologue, many investigators have
examined the putative function of UCP3.
Due to the homology of UCP3 with UCP1
(58% amino acid identity), it was believed
that UCP3 may be involved in the regulation of ener-
gy expenditure. Indeed, it has been shown that trans-
fection of yeast with hUCP3 lowers the mitochondri-
al proton gradient (8), that mitochondria from mice
overexpressing UCP3 have increased state 4 respira-
tion (10), and that mitochondria from UCP3 knock-
out mice possess decreased state 4 respiration (11).
Conversely, however, neither fasted rats in vivo (15)
nor mitochondria isolated from fasted mice in vitro
(33) showed increased mitochondrial proton leak,
despite upregulation of UCP3. This apparent dis-
crepancy between data derived from genetically mod-
ified animals and physiological interventions with
regard to the role of UCP3 in mitochondrial uncou-
pling emphasizes the need to examine the effect of a
physiological increase in UCP3 content on mito-
chondrial function in humans.
In the present study, we examined the effect of an HF
diet–induced increase of UCP3 protein content on PCr
resynthesis during recovery from anoxic exercise in
humans. As PCr resynthesis during recovery from exer-
cise is entirely dependent on mitochondrial respira-
tion, it was assumed that if the primary role of UCP3
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Figure 2
Muscle torque production recorded during 20 successive knee extensions. The
solid line represents the LF trial, and the dashed line represents the HF trial. AU,
arbitrary units.
Figure 3
Muscle UCP3 protein content assessed by Western blotting for the
LF and HF diets, expressed in arbitrary units (AU) after scanning opti-
cal density. *P < 0.05 as compared with the LF diet.
is to uncouple mitochondrial respiration, any diet-
induced increase in UCP3 would be reflected in vivo by
the rate of PCr resynthesis (particularly in this model,
in which PCr degradation during anoxic exercise is
marked). The main and novel finding of the present
study was that in intact human skeletal muscle, mito-
chondrial coupling appears not to be influenced by an
HF diet–induced increase in UCP3 protein content,
indicating that the primary role of UCP3 is not uncou-
pling. The present study also showed that feeding
humans an HF diet (60% of the energy ingested (En%)
was accounted for by dietary fat) for 7 days induces
upregulation of UCP3 at the protein level in skeletal
muscle that is directly in line with data from studies
reporting upregulation of UCP3 mRNA expression
after HF feeding (20–22).
Most of the studies examining the potential of
UCP3 to affect mitochondrial coupling have exam-
ined uncoupling under resting conditions or have
assessed state 3 and state 4 respiration — that is, in
the presence and absence of ADP, respectively. How-
ever, the net flux through the F0-F1-ATPase is not
maximal under these conditions. To generate maxi-
mal flux through the F0-F1-ATPase during recovery,
we depleted muscle PCr stores using high-intensity
exercise with limb blood flow occluded and assessed
mitochondrial coupling by measuring the rate of PCr
resynthesis during recovery with limb blood flow
reinstated. It has previously been shown that during
recovery from such exercise, the rate of PCr resynthe-
sis reflects the net ATP synthesis rate through the 
F0-F1-ATPase (34), as both are coupled at the mito-
chondrial membranes by adenine nucleotide translo-
case and mitochondrial creatine kinase and in turn,
therefore, directly reflect the extent of mitochondri-
al coupling in vivo (35). Thus, during the period of
ischemic contraction, the intramitochondrial accu-
mulation of reducing equivalents (36) will increase
the proton gradient, and in tightly coupled mito-
chondria, the energy generated by this proton gradi-
ent will be diverted to phosphorylate ADP through
F0-F1-ATPase, which will in turn determine the rate
of PCr resynthesis during recovery when limb blood
flow is reinstated. However, the flux through F0-F1-
ATPase will be diminished in uncoupled mitochon-
dria (37), thereby slowing the rate of PCr resynthe-
sis during recovery.
Irrespective of the diet received, muscle PCr resyn-
thesis was almost complete within 120 seconds of
recovery (Figure 4), as indicated by muscle PCr con-
centrations, which were similar to resting levels (38,
39). Furthermore, there were no differences in the mus-
cle PCr concentrations across the diets at any time
point. If the HF diet–induced increase in UCP3 had
affected mitochondrial coupling and thus net flux
through the F0-F1-ATPase, the rate of PCr resynthesis
would have been lower. However, we observed no effect
of UCP3 content the rate of on PCr resynthesis. Indeed,
Figure 5 demonstrates not even a hint of a relationship
between these two variables. This has led us to con-
clude that an increase in UCP3 content within the
physiological range does not affect mitochondrial cou-
pling in vivo in human skeletal muscle. This conclusion
is also supported by the similarity in acetylcarnitine
and free-carnitine concentrations across treatments
during recovery from exercise in the present study, indi-
cating that mitochondrial substrate supply and uti-
lization were similar between experimental treatments.
The outcome of the present study is in line with recent
reports showing that upregulation of UCP3 using
physiological models like fasting does not affect mito-
chondrial proton leak (14, 16) but is in contrast with in
vivo observations noted in UCP3 knockout mice (13).
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Figure 4
Muscle PCr concentrations during recovery from 20 maximal knee
extensions with limb blood flow occluded. Immediately after exer-
cise, limb blood flow was reinstated, and needle muscle biopsies
were taken 20, 60, and 120 seconds after the cessation of exercise.
Values represent means ± SD. The solid lines represent the LF diet,
and the dashed lines represent the HF diet. dw, dry weight.
Table 2
Muscle metabolites
Time Creatine Lactate Free carnitine Acetylcarnitine
(s) (mmol/kg dw) (mmol/kg dw) (mmol/kg dw) (mmol/kg dw)
Low fat High fat Low fat High fat Low fat High fat Low fat High fat
20 95.2 (20.7) 100.0 (16.6) 66.6 (28.7) 59.5 (19.5) 11.2 (4.6) 11.6 (5.4) 11.5 (2.8) 10.7 (3.3)
60 66.7 (8.3) 69.5 (8.3) 50.0 (20.8) 50.8 (21.1) 10.2 (4.5) 11.0 (4.8) 12.8 (2.7) 11.8 (3.3)
120 55.5 (5.1) 54.9 (5.3) 33.4 (13.0) 30.8 (14.4) 10.0 (3.8) 10.6 (4.8) 12.7 (1.7) 12.6 (3.3)
Muscle creatine, lactate, free-carnitine, and acetylcarnitine concentrations during recovery from 20 maximal knee extensions with limb blood flow occluded.
Immediately after exercise, limb blood flow was reinstated, and needle muscle biopsies were taken 20, 60, and 120 seconds after the cessation of exercise. Val-
ues represent means ± SD. dw, dry weight.
It could be argued that the determination of muscle
PCr concentration in the present experiment was not
sufficiently sensitive enough to detect any change in
mitochondrial function caused by the observed
increase in UCP3 protein content, and/or that the
magnitude of increase in UCP3 induced by the HF
feeding was simply insufficient to affect mitochondr-
ial coupling. However, previous studies in our labora-
tory using the same experimental model as that used
in the present study have shown clear differences in
the rates of PCr resynthesis during recovery from
ischemic contraction when mitochondrial substrate
availability has been altered (24, 40, 41), suggesting
that the determination of PCr resynthesis is indeed a
sensitive marker of mitochondrial function in vivo.
Furthermore, recent quantitative assessments of
UCP3 protein content calibrated with purified recom-
binant UCP3 showed that the abundance of UCP3 in
skeletal muscle is 200- to 700-fold lower than that of
UCP1 in brown adipose tissue (7). Therefore, the dis-
crepancy in findings between studies in which UCP3
has been modestly increased by physiological inter-
vention (such as fasting) and those in which UCP3
has been overexpressed to supraphysiological levels
could be explained by differences in the absolute
amount of UCP3 present.
Indeed, it was shown that transfection of yeast
mitochondria with recombinant human UCP3 did
not affect proton conductance markedly until UCP3
was increased to supraphysiological levels — that is,
exceeding 700% of the UCP3 concentration reported
in rat skeletal muscle (7). These findings have recent-
ly been confirmed in mitochondria from transgenic
mice overexpressing or lacking UCP3 and have led 
to the conclusion that the uncoupling observed in
models exhibiting supraphysiological amounts of
UCP3 protein is an artifact of the model used and
does not represent native uncoupling activity of the
protein (6, 7, 42). After our HF dietary intervention,
UCP3 protein content increased by 44%. On the basis
of an extrapolation of the reference concentrations
reported for UCP3 by Harper and colleagues (7), this
increase would be insufficient to affect mitochon-
drial coupling.
It could also be reasoned that, in order to maintain
ATP levels, the diet-induced increase in UCP3 protein
was counterbalanced by downregulation of other
uncoupling proteins present in skeletal muscle (e.g.,
UCP2). Recent reports have shown that, although
present at the mRNA level, expression of UCP2 at the
protein level in skeletal muscle is debatable (43).
However, to exclude any potential counter-regulato-
ry effect of UCP2, we measured UCP2 mRNA expres-
sion. In line with other reports using increased fatty
acid availability as a model (20, 21, 44), we found that
UCP2 mRNA expression was increased on the HF
diet, although this effect failed to reach significance
(4.00 ± 1.44 amol/g RNA after HF vs. 2.73 ± 0.80
amol/g RNA after LF, P = 0.07). Judging by the
increase in UCP2 mRNA, it is conceivable that UCP2
protein expression increases rather than decreases if
expression of UCP2 at the protein level occurs at all.
Thus, it is not very likely that downregulation of
UCP2 compensated for the increase in UCP3 protein
content. However, we cannot exclude the possibility
that downregulation of other yet unknown proteins
mediating a proton leak interfere with the outcome
of the present study.
Although the association between UCP3 levels and
energy expenditure is frequently reported (3, 4,
45–47) the results of the present study show that
under conditions of forced maximum flow through
the F0-F1-ATPase, increased UCP3 expression had no
major effect on mitochondrial function. This finding
is in line with the observation that subjects with an
apparent null mutation of UCP3 possess no pheno-
typic aberration with regard to systemic or mito-
chondrial respiration (48). However, this does not
exclude the possibility that under certain conditions,
mild uncoupling — as a secondary effect of the pri-
mary role of UCP3 — may still occur, thus affecting
energy expenditure. This is exemplified by a recent
report by Harper et al. showing that successful loss of
body mass following a low-calorie diet coincided with
higher UCP3 mRNA expression and increased state 4
respiration (47). Although state 4 respiration reflects
mitochondrial coupling under resting conditions in
vitro, we report no effect of UCP3 protein content on
mitochondrial function when flux through F0-F1-
ATPase is forced to its maximum. It would be of
interest to examine in vivo mitochondrial function in
the diet-resistant and diet-responsive subjects from
the study by Harper et al. and relate this to UCP3
protein rather than to mRNA levels.
In our search to determine the primary physiologi-
cal role of UCP3, we have recently reevaluated the
available data from studies involving human volun-
teers and postulated that UCP3 might act as a mito-
chondrial fatty acid anion exporter under conditions
when fatty acid delivery to the mitochondria exceeds
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Figure 5
Relationship between UCP3 protein content (arbitrary units) and
PCr resynthesis rates (mmol/kg dw/s). The filled diamonds represent
the LF diet, and the open squares represent the HF diet. Note the lack
of relation between PCr resynthesis rate and UCP3 content.
its capacity to oxidize fatty acids, rather than acting
as an uncoupling protein per se (49). Involvement of
UCP3 in fatty acid handling has previously been sug-
gested, as it was shown that carriers of the exon 6
splice donor mutation had lower fat oxidation rates
than noncarriers, without an effect on whole-body
energy expenditure (50).
Since long-chain fatty acids can only be diverted to
β-oxidation after acylation (as fatty-acyl-CoA) and the
mitochondrial matrix lacks long-chain fatty-acyl-CoA
synthetase, it is crucial for proper oxidation of long-
chain fatty acids to enter the mitochondria through
the carnitine-acyl-tranferase system. However, if
cytosolic fatty acid levels rise — for example, because of
a mismatch between fatty acid availability and oxida-
tive capacity, as is the case with prolonged consump-
tion of an HF diet — fatty acids may partition in the
mitochondrial membrane and enter the mitochondr-
ial matrix through flip-flop (51). Because of the lack
of long-chain fatty-acyl-CoA synthetase inside the
matrix, these fatty acids can not be oxidized and will
equilibrate with the pH gradient. Thus, neutral fatty
acids and fatty acid anions may accumulate within the
mitochondria and hamper mitochondrial function.
Similar to UCP1 (52), UCP3 can export nonmetabo-
lizable fatty acid anions from the mitochondrial
matrix toward the intermembrane space, which will
decrease the transmitochondrial membrane potential,
with mild uncoupling as a secondary consequence.
The increase in UCP3 protein levels, already observed
after a 7-day HF diet, is consistent with this hypothe-
sis. Furthermore, a lack of UCP3 will eventually lead to
accumulation of fatty acids inside the matrix and to
disturbances in fatty acid oxidation, which is consis-
tent with reported aberrations in fat oxidation in
humans with the exon 6 splice donor mutation (50)
and in UCP3 knockout mice (33).
In summary, the present study demonstrated that
upregulation of UCP3 by a physiological intervention
(HF feeding) did not affect the postexercise rate of
PCr resynthesis and thereby mitochondrial coupling
when flux through the F0-F1-ATPase was likely to have
been close to maximal. It is concluded that the pri-
mary role of UCP3 in human skeletal muscle is not
mitochondrial uncoupling.
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